THE CIRCULATORY REGULATION OF TPA AND UPA SECRETION, CLEARANCE, AND INHIBITION DURING EXERCISE AND DURING THE INFUSION OF ISOPROTERENOL ANDPHENYLEPHRINE
Wl. Chandler et al., THE CIRCULATORY REGULATION OF TPA AND UPA SECRETION, CLEARANCE, AND INHIBITION DURING EXERCISE AND DURING THE INFUSION OF ISOPROTERENOL ANDPHENYLEPHRINE, Circulation, 92(10), 1995, pp. 2984-2994
Background Exercise to exhaustion and infusions of isoproterenol and p
henylephrine were used to study interactions between plasminogen activ
ator regulation and the control of regional blood flow in 10 healthy m
ales. Methods and Results Experimental measurements of cardiac output,
heart rate, tissue plasminogen activator (TPA), urokinase plasminogen
activator (UPA), plasminogen activator inhibitor (PAI-1), C1-inhibito
r, and TPA/C1-inhibitor complex during the infusions and exercise were
used to develop a comprehensive fluid-phase model of the circulatory
regulation of fibrinolysis. alpha- and beta-adrenergic agonists increa
sed TPA and UPA in plasma by different mechanisms: Phenylephrine decre
ased hepatic blood flow and thus clearance while isoproterenol stimula
ted increased secretion of TPA and UPA. Exercise to exhaustion increas
ed TPA and UPA through a combination of increased secretion and decrea
sed clearance. The time course of UPA and TPA release were similar, bu
t tile magnitude of their secretion responses differed. In vivo, C1-in
hibitor bound to TPA at a rate of 553 mol(-1) . s(-1). C1-inhibitor co
ntributed equally with PAI-1 to TPA inhibition when active PAI-1 level
s were low (20 to 50 pmo/L) but was less important when active PAI-1 l
evels were high. Conclusions We conclude that secretion. inhibition, c
learance, and regional blood flow effects must all be taken into accou
nt when evaluating changes in plasminogen activator levels.